Re: hi @ all! What du u think about pfizer?
 

[ QUOTE ]
well i know that analysts are often wrong but they should be better than the average investor?!?
So if a newbie comes and doesn`t know what he is doing it would be better if he listens to them.
That`s what i mean.

[/ QUOTE ]

No, listening to no advice (and making random decisions) is better than using analyst ratings to make decisions.

If you don't know what you are doing... stick your money in an index fund.

Re: hi @ all! What du u think about pfizer?
 

[ QUOTE ]

If you don't know what you are doing... stick your money in an index fund.


[/ QUOTE ]

Are you sure about that?
So why are there any analists if they are useless? [img]/images/graemlins/wink.gif[/img]
Well i also thougt about buying an index fund but the only problem was that the best one have had too much spread (about 4,5%).
I think i am better if i put my money in stocks myself.
But i think im gonna split it, lets say about 10% of my money in funds. Is that ok?

Re: hi @ all! What du u think about pfizer?
 

[ QUOTE ]
[ QUOTE ]

If you don't know what you are doing... stick your money in an index fund.


[/ QUOTE ]

Are you sure about that?
So why are there any analists if they are useless? [img]/images/graemlins/wink.gif[/img]

[/ QUOTE ]

I didn't say analysts were useless... just that you shouldn't be making decisions based on their ratings [img]/images/graemlins/smile.gif[/img]

ahnuld gave one example of how to use their information.

[ QUOTE ]
I think i am better if i put my money in stocks myself.
But i think im gonna split it, lets say about 10% of my money in funds. Is that ok?

[/ QUOTE ]

Not if you have no clue what you are doing...

Re: hi @ all! What du u think about pfizer?
 

Had to ban Mike, rule about using a celebrity poker players name without actually being that player.

Re: hi @ all! What du u think about pfizer?
 

I personally do not think buying a big pharma stock is a good idea right now. That is all:) Actually, if I had to gamble in big pharma I would take either Lilly, GSK, or Roche. Lilly has some issues with Zyprexa patents, but Cymbalta sales should allay those concerns in 5 years and quite frankly, $50/share isn't unreasonable right now.

Pfizer is just trouble. They've got way too many mouths to feed and their backup to the Lipitor franchise has just been pulled. Its not a good buy.